You are here:
Gavi currently helps countries introduce 11 life-saving vaccines. Learn more about our support for each vaccine by clicking below.
Safe and effective human papillomavirus vaccines offer protection against 70% of all cervical cancer cases.
Gavi supports inactivated polio vaccine as part of routine immunisation programmes.
Gavi funds Japanese encephalitis catch-up campaigns. Countries then self-finance the vaccine for routine immunisation.
Gavi helps to combat measles through four types of vaccine support: measles second dose, measles-rubella, measles campaigns and outbreak responses.
The Gavi-funded measles-rubella vaccine provides a 2-in-1 shot against two devastating diseases.
Gavi-supported campaigns have reached more than 235 million people.
Gavi helps to prevent cholera outbreaks through its support to the global oral cholera vaccine stockpile.
With Gavi support, pentavalent vaccine is available in the 73 poorest countries in the world.
Gavi’s 2015 target of 45 pneumococcal introductions achieved more than one year ahead of schedule.
Gavi supports developing countries to introduce rotavirus vaccines, protecting against severe and deadly diarrhoea.
Gavi provides yellow fever support for routine immunisation, campaigns in high-risk countries and emergency stockpiles in case of outbreaks.
New and underused vaccines support
Vaccine Alliance support has contributed to immunising more than 36 million children against rotavirus diarrhoea. By the end of 2015, more than half of all Gavi-supported countries had introduced the vaccine.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2017
modal window here